PCVX - Vaxcyte Inc
Earnings Results

Vaxcyte Inc ( $PCVX )

Recent earnings result

  1. Vaxcyte EPS beats by $0.12

Events & Presentations

December 2, 2020 1:50 PM EST : Vaxcyte, Inc. at the Evercore ISI Annual HealthCONx Conference

Top Stories (PCVX)

Events & Annual meetings

Title Date Webcast
December 2, 2020 1:50 PM EST : Vaxcyte, Inc. at the Evercore ISI Annual HealthCONx Conference 12/3/2020 2:50:00 AM
November 17, 2020 12:35 PM EST : Vaxcyte, Inc. at the Jefferies Virtual London Healthcare Conference 11/18/2020 1:35:00 AM
October 5, 2020 - October 6, 2020 : Vaxcyte to Participate in Guggenheim 1st Annual Vaccines and Infectious Diseases Day 10/5/2020
September 16, 2020 2:00 PM EDT : Vaxcyte, Inc at the Cantor Virtual Global Healthcare Conference 9/17/2020 2:00:00 AM





We are a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. We utilize a cell-free protein synthesis platform to enable us to uniquely design and produce protein carriers and antigens, the critical building blocks of vaccines, in ways that we believe conventional vaccine technologies currently cannot.


Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading